These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 395959)

  • 1. Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
    Di Maio F; Neri A; Soccorsi P; Sciacca A
    Arzneimittelforschung; 1979; 29(9a):1488-90. PubMed ID: 395959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic effectiveness of creatinol O-phosphate in man.
    Cadel A; Palumbo A; Zerilli G; Pria R; Fanciulli R; Conversano S; Galbiati R
    Arzneimittelforschung; 1979; 29(9a):1485-7. PubMed ID: 94266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
    Barlattani M; Guglielmi G; Mammarella A
    Arzneimittelforschung; 1979; 29(9a):1483-5. PubMed ID: 395958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary report on electrophysiological effectiveness of creatinol O-phosphate (COP) in human subjects.
    Botti G; Bonatti V
    Arzneimittelforschung; 1979; 29(9a):1491-4. PubMed ID: 575499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
    Guglielmi G; Mammarella A
    Clin Ter; 1979 Nov; 91(4):355-82. PubMed ID: 396100
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute clinical tolerance of creatinol O-phosphate.
    Melloni GF; Minoja GM; Lureti GF; Merlo L; Pamparana F; Brusoni B
    Arzneimittelforschung; 1979; 29(9a):1447-9. PubMed ID: 575490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of creatinol O-phosphate (COP) on some experimental arrhythmias in vitro and in vivo.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1979; 29(9a):1475-7. PubMed ID: 575497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and toxicological properties of creatinol O-phosphate. A review.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1449-52. PubMed ID: 395957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice.
    Ferrini R; Miragoli G
    Arzneimittelforschung; 1979; 29(9a):1473-4. PubMed ID: 575496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective action of creatinol O-phosphate against serum CPK activity enhanced by isoprenaline in the rat.
    Marzo A; Ghirardi P
    Arzneimittelforschung; 1979; 29(9a):1471-3. PubMed ID: 575495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of creatinol O-phosphate on serum enzymes in acute myocardial infarction.
    Knippel M; Bana G; Pusterla GL
    Arzneimittelforschung; 1979; 29(9a):1480-2. PubMed ID: 575498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
    Godfraind T; Ghysel-Burton J; Merlo L
    Arzneimittelforschung; 1979; 29(9a):1465-7. PubMed ID: 575493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of creatinol-O-phosphate on the contractility changes evoked by hypoxia and ischemia in rat isolated heart.
    Godfraind T; Saleh MM
    Arzneimittelforschung; 1984; 34(9):968-72. PubMed ID: 6542374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].
    Fontana A; Lusena S
    Minerva Med; 1972 Nov; 63(82):4470-81. PubMed ID: 4642455
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and chemical properties of N- and O-phosphorylated derivatives of creatinol.
    Ferrari G; Casagrande C
    Arzneimittelforschung; 1979; 29(9a):1446-9. PubMed ID: 575489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
    Pedersen-Bjergaard O; Lindeneg O; Svendsen TL; Enk B; Fridberg M
    Ugeskr Laeger; 1986 May; 148(22):1349-51. PubMed ID: 3523916
    [No Abstract]   [Full Text] [Related]  

  • 18. Creatinol O-phosphate (COP) and muscular performance: a controlled clinical trial.
    Nicaise J
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):531-4. PubMed ID: 808375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical results and statistical analysis of the use of creatinol-O-phosphate].
    Breunig H
    Med Monatsschr; 1977 Nov; 31(11):526-9. PubMed ID: 337092
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of arrhythmias in ischemic heart disease. The role of beta blockers.
    Morganroth J
    Postgrad Med; 1988 Feb; Spec No():113-9. PubMed ID: 2894654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.